LUNG CANCER
Clinical trials for LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER trials appear
Sign up with your email to follow new studies for LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo tested to fight lung cancer in the brain
Disease control TerminatedThis study tested whether adding the drug pembrolizumab to standard chemotherapy could help patients with a type of lung cancer that had spread to their brain but wasn't causing symptoms. The goal was to see if this approach could control the cancer in the brain and body, help pa…
Matched conditions: LUNG CANCER
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New MRI tech aims to zap lung cancer more precisely
Disease control TerminatedThis study tested whether using real-time MRI scans to guide radiation therapy could be a safe and effective way to treat lung tumors located near critical organs. It compared this new MRI-guided approach to the standard CT-guided method. The goal was to see if the MRI technique …
Matched conditions: LUNG CANCER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Early-Stage trial halted for advanced lung cancer treatment
Disease control TerminatedThis study aimed to test the effectiveness and safety of a combination treatment for adults with advanced non-small cell lung cancer (NSCLC) who have specific, less common genetic mutations. The treatment combined a targeted pill (osimertinib) with standard chemotherapy drugs. Th…
Matched conditions: LUNG CANCER
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New cancer drug enters human testing for advanced tumors
Disease control TerminatedThis first-in-human study tested a new cancer drug called PHN-010 in patients with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check the drug's safety, determine the right dose, and see if it could shrink tumors. The trial incl…
Matched conditions: LUNG CANCER
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists hunt for lung Cancer's genetic fingerprint
Knowledge-focused TerminatedThis study aimed to find genetic markers that could predict how quickly squamous cell lung cancer might worsen. Researchers collected small tissue and blood samples from patients who had or were having lung procedures. The goal was to analyze the DNA from these samples to identif…
Matched conditions: LUNG CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC